X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (14) 14
humans (12) 12
cancer (7) 7
animals (6) 6
article (6) 6
mutation (6) 6
mice (5) 5
mice, inbred c57bl (5) 5
mice, knockout (5) 5
mutations (5) 5
oncology (5) 5
schistosomiasis (5) 5
tumors (5) 5
abridged index medicus (4) 4
acquired-resistance (4) 4
deoxyribonucleic acid--dna (4) 4
inflammation (4) 4
lung cancer (4) 4
male (4) 4
pulmonary hypertension (4) 4
therapy (4) 4
biomarkers, tumor - blood (3) 3
carcinoma, non-small-cell lung - pathology (3) 3
circulating tumor dna (3) 3
diagnosis (3) 3
disease models, animal (3) 3
female (3) 3
gene expression profiling (3) 3
genetic aspects (3) 3
genomes (3) 3
lung neoplasms - genetics (3) 3
lung neoplasms - pathology (3) 3
mice, transgenic (3) 3
quantification (3) 3
respiratory system (3) 3
activation (2) 2
adult (2) 2
aged (2) 2
algorithms (2) 2
alterations (2) 2
american fiction (2) 2
azd9291 (2) 2
biopsy (2) 2
cancer therapies (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
carcinoma, non-small-cell lung - genetics (2) 2
cardiac & cardiovascular systems (2) 2
cell biology (2) 2
cell line, tumor (2) 2
circulating tumor dna - genetics (2) 2
cytokines (2) 2
dna (2) 2
drug resistance, neoplasm - genetics (2) 2
eggs (2) 2
expression (2) 2
gene expression (2) 2
gene mutations (2) 2
hek293 cells (2) 2
hypertension (2) 2
hypertension, pulmonary - etiology (2) 2
identification (2) 2
intratumor heterogeneity (2) 2
landscape (2) 2
lung neoplasms - drug therapy (2) 2
met amplification (2) 2
metastases (2) 2
methods (2) 2
middle aged (2) 2
multidisciplinary sciences (2) 2
original research (2) 2
parasitic diseases (2) 2
patients (2) 2
protein kinase inhibitors - pharmacology (2) 2
recurrence (2) 2
reverse transcriptase polymerase chain reaction (2) 2
schistosoma mansoni (2) 2
schistosomiasis mansoni - complications (2) 2
sensitivity (2) 2
survival (2) 2
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
abnormalities (1) 1
acrylamides - pharmacology (1) 1
acrylamides - therapeutic use (1) 1
acute lymphoblastic-leukemia (1) 1
aged, 80 and over (1) 1
alleles (1) 1
allergic inflammation (1) 1
allergies (1) 1
american authors (1) 1
american recovery & reinvestment act 2009-us (1) 1
american short stories (1) 1
aminopyridines - pharmacology (1) 1
analysis (1) 1
animal models (1) 1
antibodies (1) 1
antigen-antibody reactions (1) 1
antigens (1) 1
antineoplastic agents - pharmacology (1) 1
appraisal (1) 1
appraisal of books (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Communications, ISSN 2041-1723, 06/2016, Volume 7, Issue 1, p. 11815
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2017, Volume 49, Issue 12, pp. 1693 - 1704
A widespread approach to modern cancer therapy is to identify a single oncogenic driver gene and target its mutant-protein product (for example, EGFR-inhibitor... 
HETEROGENEITY | CELLS | ACTIVATION | CIRCULATING TUMOR DNA | MET AMPLIFICATION | GENETICS & HEREDITY | ACQUIRED-RESISTANCE | MUTATIONS | INHIBITOR | EXPRESSION | AZD9291 | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Cell Proliferation - genetics | Class I Phosphatidylinositol 3-Kinases - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Kaplan-Meier Estimate | Lung Neoplasms - pathology | beta Catenin - genetics | Wnt Signaling Pathway - drug effects | Wnt Signaling Pathway - genetics | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Gene Expression Regulation, Neoplastic - drug effects | Mutation | Cyclin-Dependent Kinases - genetics | Neoplasm Staging | Clonal Evolution | Care and treatment | Gene mutations | Lung cancer | Development and progression | Genetic aspects | Drug resistance | Health aspects | Therapy | Cell survival | Genomic analysis | Wnt protein | Epidermal growth factor receptors | Genes | Biological evolution | Genomes | Metastasis | Kinases | Patients | Cyclin-dependent kinase 4 | Clinical outcomes | Metastases | Datasets | Alterations | Inhibitors | Genetic testing | Deoxyribonucleic acid--DNA | Cancer | Fibroblast growth factor receptors | Tumors
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2016, Volume 113, Issue 52, pp. E8379 - E8386
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2018, Volume 36, Issue 28, pp. 2845 - 2853
PurposeOutcomes for patients with diffuse large B-cell lymphoma remain heterogeneous, with existing methods failing to consistently predict treatment failure.... 
FDG-PET | SURVIVAL | INTERIM | CONSOLIDATION | THERAPY | ONCOLOGY | END-POINT | HODGKIN | CHEMOTHERAPY | TRANSPLANTATION | Life Sciences | Cancer | ORIGINAL REPORTS
Journal Article
Pulmonary Circulation, ISSN 2045-8932, 06/2014, Volume 4, Issue 2, pp. 289 - 299
There is significant evidence that Th2 (T helper 2)-mediated inflammation supports the pathogenesis of both human and experimental animal models of pulmonary... 
Animal models | Vascular diseases | Lungs | Disease models | Original Research | Vasoconstriction | Inflammation | Ova | Post hoc | Renovations | Eggs
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. 4055 - 4055
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 130 - 130
Abstract Background: The prognosis for diffuse large B-cell lymphoma (DLBCL) patients who fail initial therapy remains poor. Current prognostic methods to... 
Journal Article
CANCER DISCOVERY, ISSN 2159-8274, 04/2019, Volume 9, Issue 4, pp. 500 - 509
Current regimens for the detection and surveillance of bladder cancer are invasive and have suboptimal sensitivity. Here, we present a novel high-throughput... 
SENSITIVITY | MUTATIONS | CYTOLOGY | ONCOLOGY | COMPREHENSIVE MOLECULAR CHARACTERIZATION
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 12/2016, Volume 113, Issue 52, p. E8379
  Circulating tumor cells (CTCs) are established cancer biomarkers for the "liquid biopsy" of tumors. Molecular analysis of single CTCs, which recapitulate... 
Biopsy | Lung cancer | Biomarkers | Mutation | Cancer therapies | Tumors
Journal Article
Journal of Oncology, ISSN 1687-8450, 2017, Volume 2017, pp. 4517834 - 5
Genetic sequencing of malignancies has become increasingly important to uncover therapeutic targets and capture the tumor's dynamic changes to drug sensitivity... 
OSIMERTINIB | THERAPY | ONCOLOGY | METASTASES | ACQUIRED-RESISTANCE | EGFR MUTATIONS | KRAS | ERLOTINIB | AZD9291 | Usage | Lung cancer | Genetic aspects | Research | Nucleotide sequencing | Diagnosis | DNA sequencing | Cancer | Review
Journal Article